Vitamin‐C ‐dependent downregulation of the citrate metabolism pathway potentiates pancreatic ductal adenocarcinoma growth arrest
Molecular Oncology · 2024
DOI: 10.1002/1878-0261.13616 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Oncology, 2024. Verfasst von Aiora Cenigaonandia-Campillo und 16 weiteren Autor:innen. Beteiligte Einrichtung: Translational Oncology Division, Oncohealth Institute, IIS-Fundación Jimenez Diaz-UAM (Madrid), Spain. Hauptthemen laut MEDLINE: Carcinoma, Pancreatic Ductal, Ascorbic Acid, Pancreatic Neoplasms, Citric Acid. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universidad Católica San Antonio de Murcia, O.N.G Otro Mundo Es Posible, Ministerio de Ciencia y Tecnología.
Abstract (Originalsprache)
In pancreatic ductal adenocarcinoma (PDAC), metabolic rewiring and resistance to standard therapy are closely associated. PDAC cells show enormous requirements for glucose‐derived citrate, the first rate‐limiting metabolite in the synthesis of new lipids. Both the expression and activity of citrate synthase (CS) are extraordinarily upregulated in PDAC. However, no previous relationship between gemcitabine response and citrate metabolism has been documented in pancreatic cancer. Here, we report for the first time that pharmacological doses of vitamin C are capable of exerting an inhibitory action on the activity of CS, reducing glucose‐derived citrate levels. Moreover, ascorbate targets citrate metabolism towards the de novo lipogenesis pathway, impairing fatty acid synthase (FASN) and ATP citrate lyase (ACLY) expression. Lowered citrate availability was found to be directly associated with diminished proliferation and, remarkably, enhanced gemcitabine response. Moreover, the deregulated citrate‐derived lipogenic pathway correlated with a remarkable decrease in extracellular pH through inhibition of lactate dehydrogenase (LDH) and overall reduced glycolytic metabolism. Modulation of citric acid metabolism in highly chemoresistant pancreatic adenocarcinoma, through molecules such as vitamin C, could be considered as a future clinical option to improve patient response to standard chemotherapy regimens.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Translational Oncology Division, Oncohealth Institute, IIS-Fundación Jimenez Diaz-UAM (Madrid), Spain.
- Molecular Recognition and Encapsulation Research Group (REM), Health Sciences Department, Universidad Católica de Murcia (UCAM), Spain.
- Bioinformatics and High-Performance Computing Research Group (BIO-HPC), Computer Engineering Department, Universidad Católica de Murcia (UCAM), Spain.
- Centro de Biología Molecular Severo Ochoa, Consejo Superior de Investigaciones Científicas, Universidad Autónoma de Madrid (CSIC-UAM), Spain.
- Instituto Universitario de Biología Molecular-UAM (IUBM-UAM), Departamento de Biología Molecular, Universidad Autónoma de Madrid, Spain.
- Hospital Clínico San Carlos (HCSC), Madrid, Spain.
ORCID-Profile: Aiora Cenigaonandia-Campillo, Jesús Garcia-Foncillas, Óscar Aguilera
Förderung
- Universidad Católica San Antonio de Murcia
- O.N.G Otro Mundo Es Posible
- Ministerio de Ciencia y Tecnología
- Centro para el Desarrollo Tecnológico Industrial
- Centre for Industrial Technological Development
Zitieren
APA
Cenigaonandia-Campillo, A., Garcia-Bautista, A., Rio-Vilariño, A., Cebrian, A., Del Puerto, L., Pellicer, J. A., Gabaldón, J. A., Pérez-Sánchez, H., Carmena-Bargueño, M., Meroño, C., Traba, J., Fernandez-Aceñero, M. J., Baños-Herraiz, N., Mozas-Vivar, L., Núñez-Delicado, E., Garcia-Foncillas, J., & Aguilera, Ó. (2024). Vitamin‐C ‐dependent downregulation of the citrate metabolism pathway potentiates pancreatic ductal adenocarcinoma growth arrest. Molecular Oncology. https://doi.org/10.1002/1878-0261.13616
Vancouver
Cenigaonandia-Campillo A, Garcia-Bautista A, Rio-Vilariño A, Cebrian A, Del Puerto L, Pellicer JA, et al. Vitamin‐C ‐dependent downregulation of the citrate metabolism pathway potentiates pancreatic ductal adenocarcinoma growth arrest. Molecular Oncology. 2024. doi:10.1002/1878-0261.13616
BibTeX
@article{CenigaonandiaCampillo2024,
author = {Cenigaonandia-Campillo, Aiora and Garcia-Bautista, Ana and Rio-Vilariño, Anxo and Cebrian, Arancha and Del Puerto, Laura and Pellicer, José Antonio and Gabaldón, José Antonio and Pérez-Sánchez, Horacio and Carmena-Bargueño, Miguel and Meroño, Carolina and Traba, Javier and Fernandez-Aceñero, María Jesús and Baños-Herraiz, Natalia and Mozas-Vivar, Lorena and Núñez-Delicado, Estrella and Garcia-Foncillas, Jesús and Aguilera, Óscar},
title = {Vitamin‐C ‐dependent downregulation of the citrate metabolism pathway potentiates pancreatic ductal adenocarcinoma growth arrest},
journal = {Molecular Oncology},
year = {2024},
doi = {10.1002/1878-0261.13616}
}
EUVIMED